Order no. |
Antibody specificity / reagent / analyte |
Ig |
Substrate |
Species |
Format
|
EI 2570-9601 G |
Cytomegalovirus |
IgG |
|
2/20/200 RU/ml |
96 x 01 |
EI 2570-9601 M |
Cytomegalovirus (CMV) incl. IgG/RF absorbent |
IgM |
semi-quantitative |
96 x 01 | |
EI 2570-9601-1 G | Cytomegalovirus (CMV) avidity determination |
IgG |
2/20/200 RU/ml |
96 x 01 | |
EI 2570-9601- 2 M | Cytomegalovirus (CMV) p52 incl. IgG/RF absorbent |
IgM |
semi-quantitative |
96 x 01 | |
EI 2570-9601-L G | Cytomegalovirus (CMV) antibody determination in CSF |
IgG |
5/25/50/100U |
96 x 01 | |
DN 2410-1601-11 G DN 2410-6401-11 G |
"TO.R.C.H. 10" (Toxoplasma gondii, Rubella virus, CMV, HSV-1, HSV-2, Bordetella pertussis, Chlamydia trachomatis, Parvovirus B19, Treponema pallidum, VZV separately) |
IgG |
EUROLINE | 16 strips 64 strips |
|
DN 2410-1601-4 G DN 2410-6401-4 G |
"TO.R.C.H. Profile" (Toxoplasma gondii, Rubella virus, CMV, HSV-1, HSV-2 separately) |
IgG |
EUROLINE | 16 strips 64 strips |
|
DN 2410-1601-4 M DN 2410-6401-4 M |
"TO.R.C.H. Profile" (Toxoplasma gondii, ROP1, Rubella virus, CMV, HSV-1, HSV-2 separately) |
IgM |
EUROLINE | |
16 strips 64 strips |
FI 2570-1005 A FI 2570-1010 A FI 2570-1005 G FI 2570-1010 G FI 2570-1005 M FI 2570-1010 M FI 2570-1005 X |
Cytomegalovirus (CMV) |
IgA IgG IgM avidity test |
infected cells |
EU 168 |
10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) |
FI 2822-1001-1 G FI 2822-1002-1 G FI 2822-1001-1 M * FI 2822-1002-1 M * |
Exanthema Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, HHV-6, Rubella virus*, Measles virus,Mumps virus field B: VZV, EBV-CA, EBV-EA, Treponema pallidum field C: HSV-1 and -2, Coxsackie virus type B1 and A9 field D: Echo virus type 7, Borrelia afzelii, burgdorferi (CH),garinii field E: CMV, Candida albicans, krusei*, tropicalis* |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
FI 2823-1001-1 G * FI 2823-1002-1 G * FI 2823-1001-1 M * FI 2823-1002-1 M * |
Lymphadenitis Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, HIV-1*and 2*, HHV-6, Rubella virus* field B: measles virus, Mumps virus, Adenovirus type 3, Parainfluenza virus type 1 field C: EBV-CA, EBV-EA, Toxoplasma gondii, Treponema pallidum field D: HSV-1 and -2, CMV, Coxsackie virus type B5 field E: Coxsackie virus type A9, Bartonella henselae, Chlamydia trachomatis and pneumoniae |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
FI 2824-1001-1 G FI 2824-1002-1 G FI 2824-1001-1 M * FI 2824-1002-1 M * |
Central Nervous System Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV field B: Adenovirus type 3, EBV-CA, Treponema pallidum, Toxoplasma gondii field C: HSV-1 and -2, Coxsackie virus type B1 and A7 field D: Echo virus type 7, Borr. afzelii, burgdorferi (CH),garinii field E:CMV, Haemophilus influenzae*, Listeria monocytogenes 1/2a end 4b |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
FI 2825-1001-1 G FI 2825-1002-1 G FI 2825-1001-1 M FI 2825-1002-1 M |
Myocarditis Profile 1 (consisting of 17 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus Typ B, Parainfluenza virus type 1 and 2, Mycoplasma pneumoniae field C: CMV, Coxsackie virus type B1 and A16, Echo virus type 7 field D: Borrelia afzelii, burgdorferi (CH), garinii, Chlamydia pneumoniae |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
ZF 1120-0101 | additive for CMV buffer (1.0 ml as admixture for 1.0 liter PBS) |
1.0 ml | |||
ZF 1121-0530 | CMV buffer (IIFT) | 5 x 30.0 ml (ready for use) in EUROTank | |||
CI 2570-0101 A | antibodies against Cytomegalovirus (CMV) IgA positive control |
IgA | 0.1 ml | ||
CI 2570-0101 Z | Cytomegalovirus (CMV) negative control |
IgA, IgG, IgM | 0.1 ml | ||
CI 2570-0101 G | antibodies against Cytomegalovirus (CMV) IgG positive control |
IgG | 0.1 ml | ||
CI 2570-0101 H | high-avid antibodies against Cytomegalovirus (CMV) IgG positive control |
avidity test | 0.1 ml | ||
CI 2570-0101 M | antibodies against Cytomegalovirus (CMV) IgM positive control |
IgM | 0.1 ml | ||
CI 2570-0101 X | low-avid antibodies against Cytomegalovirus (CMV) IgG positive control |
avidity test | 0.1 ml |
*) Currently not available as IVD in the European Union.
Order no. |
Antibody specificity / reagent / analyte |
Ig |
Substrate |
Species |
Format
|
EI 2570-9601 G |
Cytomegalovirus |
IgG |
|
2/20/200 RU/ml |
96 x 01 |
EI 2570-9601 M |
Cytomegalovirus (CMV) incl. IgG/RF absorbent |
IgM |
semi-quantitative |
96 x 01 | |
EI 2570-9601-1 G | Cytomegalovirus (CMV) avidity determination |
IgG |
2/20/200 RU/ml |
96 x 01 | |
EI 2570-9601- 2 M | Cytomegalovirus (CMV) p52 incl. IgG/RF absorbent |
IgM |
semi-quantitative |
96 x 01 | |
EI 2570-9601-L G | Cytomegalovirus (CMV) antibody determination in CSF |
IgG |
5/25/50/100U |
96 x 01 | |
DN 2410-1601-11 G DN 2410-6401-11 G |
"TO.R.C.H. 10" (Toxoplasma gondii, Rubella virus, CMV, HSV-1, HSV-2, Bordetella pertussis, Chlamydia trachomatis, Parvovirus B19, Treponema pallidum, VZV separately) |
IgG |
EUROLINE | 16 strips 64 strips |
|
DN 2410-1601-4 G DN 2410-6401-4 G |
"TO.R.C.H. Profile" (Toxoplasma gondii, Rubella virus, CMV, HSV-1, HSV-2 separately) |
IgG |
EUROLINE | 16 strips 64 strips |
|
DN 2410-1601-4 M DN 2410-6401-4 M |
"TO.R.C.H. Profile" (Toxoplasma gondii, ROP1, Rubella virus, CMV, HSV-1, HSV-2 separately) |
IgM |
EUROLINE | |
16 strips 64 strips |
FI 2570-1005 A FI 2570-1010 A FI 2570-1005 G FI 2570-1010 G FI 2570-1005 M FI 2570-1010 M FI 2570-1005 X |
Cytomegalovirus (CMV) |
IgA IgG IgM avidity test |
infected cells |
EU 168 |
10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) 10 x 10 (test system) 10 x 05 (test system) |
FI 2822-1001-1 G FI 2822-1002-1 G FI 2822-1001-1 M * FI 2822-1002-1 M * |
Exanthema Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, HHV-6, Rubella virus*, Measles virus,Mumps virus field B: VZV, EBV-CA, EBV-EA, Treponema pallidum field C: HSV-1 and -2, Coxsackie virus type B1 and A9 field D: Echo virus type 7, Borrelia afzelii, burgdorferi (CH),garinii field E: CMV, Candida albicans, krusei*, tropicalis* |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
FI 2823-1001-1 G * FI 2823-1002-1 G * FI 2823-1001-1 M * FI 2823-1002-1 M * |
Lymphadenitis Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, HIV-1*and 2*, HHV-6, Rubella virus* field B: measles virus, Mumps virus, Adenovirus type 3, Parainfluenza virus type 1 field C: EBV-CA, EBV-EA, Toxoplasma gondii, Treponema pallidum field D: HSV-1 and -2, CMV, Coxsackie virus type B5 field E: Coxsackie virus type A9, Bartonella henselae, Chlamydia trachomatis and pneumoniae |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
FI 2824-1001-1 G FI 2824-1002-1 G FI 2824-1001-1 M * FI 2824-1002-1 M * |
Central Nervous System Profile 1 (consisting of 21 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV field B: Adenovirus type 3, EBV-CA, Treponema pallidum, Toxoplasma gondii field C: HSV-1 and -2, Coxsackie virus type B1 and A7 field D: Echo virus type 7, Borr. afzelii, burgdorferi (CH),garinii field E:CMV, Haemophilus influenzae*, Listeria monocytogenes 1/2a end 4b |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
FI 2825-1001-1 G FI 2825-1002-1 G FI 2825-1001-1 M FI 2825-1002-1 M |
Myocarditis Profile 1 (consisting of 17 different substrates) |
IgG IgM |
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2) field B: Influenza virus Typ B, Parainfluenza virus type 1 and 2, Mycoplasma pneumoniae field C: CMV, Coxsackie virus type B1 and A16, Echo virus type 7 field D: Borrelia afzelii, burgdorferi (CH), garinii, Chlamydia pneumoniae |
10 x 01 (test system) 10 x 02 (test system) 10 x 01 (test system) 10 x 02 (test system) |
|
ZF 1120-0101 | additive for CMV buffer (1.0 ml as admixture for 1.0 liter PBS) |
1.0 ml | |||
ZF 1121-0530 | CMV buffer (IIFT) | 5 x 30.0 ml (ready for use) in EUROTank | |||
CI 2570-0101 A | antibodies against Cytomegalovirus (CMV) IgA positive control |
IgA | 0.1 ml | ||
CI 2570-0101 Z | Cytomegalovirus (CMV) negative control |
IgA, IgG, IgM | 0.1 ml | ||
CI 2570-0101 G | antibodies against Cytomegalovirus (CMV) IgG positive control |
IgG | 0.1 ml | ||
CI 2570-0101 H | high-avid antibodies against Cytomegalovirus (CMV) IgG positive control |
avidity test | 0.1 ml | ||
CI 2570-0101 M | antibodies against Cytomegalovirus (CMV) IgM positive control |
IgM | 0.1 ml | ||
CI 2570-0101 X | low-avid antibodies against Cytomegalovirus (CMV) IgG positive control |
avidity test | 0.1 ml |
*) Currently not available as IVD in the European Union.